Overview

Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)

Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
To assess response rate of docetaxel and S-1 combination in metastatic or recurrent head and neck squamous cell carcinoma
Phase:
Phase 2
Details
Lead Sponsor:
Seoul National University Hospital
Collaborator:
Clinical Research Center for Solid Tumor, Korea
Treatments:
Docetaxel